The optimal dosing of gemtuzumab ozagamicin: where to go from here?

• Theo de Witte,
• Sergio Amadori

Affiliations

Theo de Witte

Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands

Sergio Amadori

Tor Vergata University Hospital, Rome, Italy